@inbook{0274e0ec61144608b599e348b7adc9d1,
title = "Drugs that affect blood coagulation, fibrinolysis and hemostasis",
abstract = "This chapter reviewed 2019 publications that identify side effects of drugs that affect blood coagulation, fibrinolysis and hemostasis. Publications on warfarin, apixaban, dabigatran, rivaroxaban, edoxaban, betrixaban, bivalirudin, argatroban, unfractionated heparin, low molecular weight heparin, fondaparinux, aminocaproic acid, tranexamic acid, idarucizumab, andexanet alfa, and tissue plasminogen activators have been reviewed. In addition to the well-known risks of these medications such as bleeding or thrombotic events, rare adverse events reports were recognized.",
keywords = "Adverse events, Adverse reactions, Aminocaproic acid, Andexanet alfa, Apixaban, Argatroban, Betrixaban, Bivalirudin, Dabigatran, Direct acting anticoagulants, Edoxaban, Fondaparinux, Idarucizumab, Low molecular weight heparin, Rivaroxaban, Side effects, Tissue plasminogen activators, Tranexamic acid, Unfractionated heparin, Warfarin",
author = "Choi, \{Seohyun (Claudia)\} and Jessica Wilczynski and Danielle Tompkins and Jimmy Gonzalez",
note = "Publisher Copyright: {\textcopyright} 2020 Elsevier B.V.",
year = "2020",
month = jan,
doi = "10.1016/bs.seda.2020.08.011",
language = "English (US)",
isbn = "9780128203309",
series = "Side Effects of Drugs Annual",
publisher = "Elsevier B.V.",
pages = "337--360",
editor = "Ray, \{Sidhartha D.\}",
booktitle = "A Worldwide Yearly Survey of New Data in Adverse Drug Reactions",
}